Nessuna connessione a internet — viene mostrata la versione salvata della pagina.

Scilex Holding Co…

USUSD
← Allo screener

Scilex Holding Company (US:SCLX) — Biotechnology: Biological Products (No Diagnostic Substances). Numero di borse in cui sono quotate le azioni della società: 1. In questa pagina: prezzo e grafico, dividendi, principali azionisti e cronologia del numero di azioni.

Informazioni sull'azienda

Sito web
scilexholding.com
Settore
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Sede centrale
PALO ALTO, United States
Amministratore delegato
Dr. Henry H. Ji Ph.D.
Dipendenti
34
Azioni in circolazione
8.49 Mln al 2026-08-10
Flottante
5.69 Mln
Capitalizzazione di mercato
31.02 Mln USD
Insider
11.67%
Investitori istituzionali
8.52%
Settore (SIC)
Biological Products, (No Diagnostic Substances)
Payout ratio
perdita
FCF
−17.8 Mln USD
FCF < 0
Debito
28.8 Mln USD
Serie di dividendi
—
Utili, FCF e dividendi pagati — per i 12 mesi fino a 30.06.2026 (l'ultimo rapporto dell'azienda).
Descrizione

Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. The company also develops three product candidates, including SP-102 (10 mg, dexamethasone sodium phosphate viscous gel - SEMDEXA), a novel viscous gel formulation of a used corticosteroid for epidural injections, which has completed a phase 3 study to treat lumbosacral radicular pain or sciatica; SP-103 (lidocaine topical system) 5.4%, a formulation of ZTlido for the treatment of chronic neck pain and low back pain (LBP) that has completed a phase 2 trial; and SP-104 (4.5 mg low-dose naltrexone hydrochloride delayed-release capsules), a novel low-dose delayed-release naltrexone hydrochloride, which has completed phase 1 trials for the treatment of fibromyalgia. It has an agreement with Oishi and Itochu to develop lidocaine tape products, including ZTlido and SP-103; Lifecore Biomedical, LLC for clinical trial material manufacturing and development services for SEMDEXA; and Tulex Master, which develops, tests, and manufactures clinical supplies of SP-104. Scilex Holding Company is based in Palo Alto, California.

Borse e ticker

BorsaTickerValutaPrezzoTipo
US USA StocksSCLXUSD2.96 -15.19%azioni ordinarie

Prezzo su 3 mesi

US:SCLX · USD
giorno di rialzo giorno di ribasso data di stacco del dividendo data di pagamentoPassa il mouse / tocca un giorno — prezzi di apertura, chiusura, massimo e minimo

Dividendi

Nessun pagamento di dividendi trovato (controllato 09.10.2026). Probabilmente la società non distribuisce dividendi.

Notizie di questa settimana

Ancora nessuna notizia dal sito della società.

pubblicità

Principali azionisti

DetentoreQuotaAzioniData del rapporto
JI HENRY H (Officer and…≈8.02%680 8842024-10-31
Vanguard Capital Managem…3.55%301 2922026-06-30
SHAH JAISIM (Chief Execu…≈3.48%295 2152024-12-18
VANGUARD INDEX FUNDS-Van…2.56%217 5102026-06-30
CHUN JAY (Director)≈1.33%112 5112024-10-18
Blackrock Inc.1.29%109 4172026-06-30
VANGUARD INDEX FUNDS-Van…0.9%76 2302026-06-30
Vanguard Fiduciary Trust…0.54%45 8222026-06-30
Jacobs Levy Equity Manag…0.48%41 1632026-06-30
State Street Corporation0.42%35 3762026-06-30
UBS Group AG0.39%33 3762026-06-30
Renaissance Technologies…0.39%33 0642026-06-30
Citadel Advisors Llc0.32%27 4972026-06-30
WU YUE ALEXANDER (Direct…≈0.29%25 0002024-10-17
iShares Trust-iShares Mi…0.28%23 9352026-08-31
MA STEPHEN HOI (Chief Fi…≈0.27%22 8402024-10-16
Price (T.Rowe) Associate…0.25%20 9202026-06-30
Ashton Thomas Private We…0.22%18 4822026-06-30
-Price (T.Rowe) U.S. Equ…0.17%14 0202026-06-30
T. ROWE PRICE INDEX TRT,…0.08%6 9002026-06-30
VANGUARD Inst. INDEX Fd.…0.04%3 8052026-06-30
VANGUARD VALLEY FORGE FU…0.04%3 7472026-06-30
FOLLOWWILL DORMAN (Direc…≈0.03%2 3002024-10-18
LEMUS DAVID (Director)≈0.02%2 0002024-10-17
EQ Advisors Trust-1290 V…0.02%1 6832026-06-30
Brighthouse Funds Trust…0.01%6272026-06-30
STATE STREET Inst. INVES…0%1202026-06-30
SCILEX HOLDING CO (Benef…—244.45 Mln2025-12-30